A cross-sectional national questionnaire survey assessing the clinical attitudes of members of the British Menopause Society to the management of women with premature ovarian insufficiency

Monica Mittal, Michael Savvas, Nitish Narvekar, Nick Panay, Haitham Hamoda
Post reproductive health · 2014 · vol. 20(3) , pp. 90–97 · doi:10.1177/2053369114540883 · PMID:24973048 · W2057010815
Observational OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

A survey of British Menopause Society members found varied management preferences for premature ovarian insufficiency, with a majority favoring hormone replacement therapy over combined oral contraceptives but significant differences in specific treatment choices.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To explore the current clinical attitudes of members of the British Menopause Society to the management of premature ovarian insufficiency. DESIGN: An electronic cross-sectional questionnaire survey. SETTING: Members of the British Menopause Society. POPULATION: All members of the British Menopause Society with a valid email address. METHOD: Completion of an electronic survey. MAIN OUTCOME MEASURES: Investigations and treatment options and preferences for the management of women with premature ovarian insufficiency. RESULTS: A total of 130 questionnaires were returned and analysed. The majority of responses were from Hospital Consultants (n = 55/130; 42.3%). A total of 53/124 (42.7%) clinicians routinely performed a bone density scan. A total of 73/130 (56.2%) clinicians would prescribe hormone replacement therapy in preference to combined ethinyl estradiol and progesterone (COC; 27/130, 20.8%). A total of 44/108 (40.7%) routinely prescribed oral estradiol in preference to transdermal administration (62/108, 57.4%). A total of 26/128 (20.3%) prescribed oral micronised progesterone, 31/128 (24.2%) oral progestogens, while 42/128 (32.8%) preferred the intra-uterine system. Fertility concerns remain an important aspect of care, with 33.9% (n = 39/115) of clinicians indicating that more than 50% of their patients had a concern regarding their fertility. CONCLUSION: The majority of clinicians indicated a preference for hormone replacement therapy instead of the COC as their choice of hormone replacement in women with premature ovarian insufficiency. However, there was a significant variation in practices. This information can be useful in counselling women and in guiding clinical practitioners. The results highlight the need for further research to determine the optimal regimens for the management of women with premature ovarian insufficiency.

My notes (saved in your browser only)

MeSH descriptors

Attitude of Health Personnel Menopause, Premature Practice Patterns, Physicians' Primary Ovarian Insufficiency Women's Health Adult Cross-Sectional Studies Estrogen Replacement Therapy Female Gonadotropins Gonadotropins Gynecology Gynecology Humans Population Surveillance Practice Patterns, Physicians' Primary Ovarian Insufficiency Primary Ovarian Insufficiency Surveys and Questionnaires United Kingdom

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (32)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-11T05:19:45.559451+00:00
pubmed
last seen: 2026-10-08T21:13:52.854593+00:00
unpaywall
last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0 · commercial use OK